I have in my earlier editorials, delved on the issues of authorship, plagiarism, duplicate publication and copyright transfers. However, there is a continued need for us to adhere to the most stringent standards for patient informed consent and confidentiality in clinical research and publishing along with other ethical considerations that should be paramount in publishing any scientific study. This editorial will briefly address some of these ethical considerations.

HUMAN SUBJECTS AND CONFIDENTIALITY {#sec1-1}
==================================

If our research involves human subjects or participants, it is mandatory that we clear our protocol with the Ethical Committee or a similar body at our institution, whether we work in a college, at a hospital or at a private company. We regularly perform such steps as coding our subjects or participants by numbers or alphabets rather than using their real names, coding sites and other identifying data in a similar manner and minimizing access to the raw data. However, we must consider confidentiality again when findings are published, even if such measures have been taken during data collection. We should ensure that subject names and hospital numbers are not revealed. Ensure that in any photos of subjects their eyes are obscured so they cannot be identified. Ensure subjects have provided consent for the publication of their photos/laboratory results.

HONESTY IN REPORTING {#sec1-2}
====================

Our research requires that we be as clear as possible in reporting the procedures we use to obtain our results. Obviously, being honest in accounting for our work is essential. How do we know what constitutes dishonesty or untruthfulness? Guenin\[[@ref1]\] suggests two major areas of untruthfulness with which we should be concerned: Misrepresentation, in which one intentionally presents a material falsehood or, by omitting certain facts, allows a falsehood to be assumed and plagiarism, in which one takes undeserved credit for other\'s ideas or work. Fabrication of data or results is not only unethical, but can lead to danger for others if, for example, treatment or policy decisions are made on the basis of false findings. Another ethical issue relates to publication of so called "negative findings". We may have gone through the trouble of testing a hypothesis or seeking an interesting finding, only to find that our hypothesis did not hold up, or nothing new or interesting has emerged. Do we then stop all work? No. Some authors have suggested that failure to report research findings in itself constitutes scientific misconduct.\[[@ref2]\]

We should reserve acknowledgements for those who make a significant contribution to the paper but do not meet the criteria for authorship; however, the length and detail of acknowledgements should be kept to a minimum.\[[@ref3]\] We should consider acknowledging the following people/groups at the end of our manuscript: (1) Companies or corporations that donate materials or services for our research, (2) companies or institutions that provide grants in support of our research, (3) people who provide statistical services or make other contributions to the preparation of the manuscript but receive no compensation and (4) mentors or advisors who provide input or review free of charge.

CONFLICT OF INTEREST {#sec1-3}
====================

We should declare any relationships which could be viewed upon as a conflict of interest. This helps in upholding trust in the credibility of our papers. Sources of funding for the study should also be listed.

REGISTRATION {#sec1-4}
============

Journals are increasingly adopting a policy whereby studies must be registered in a public trials registry as a condition of consideration for publication in the journal. The Clinical Trials Registry - India (CTRI), hosted at the Indian Council of Medical Research\'s National Institute of Medical Statistics, is a free and online public record system for registration of clinical trials being conducted in India that was launched on 20^th^ July 2007 ([www.ctri.nic.in](http://www.ctri.nic.in)). Initiated as a voluntary measure, since 15^th^ June 2009, trial registration in the CTRI has been made mandatory by the Drugs Controller General (India) ([www.cdsco.nic.in](http://www.cdsco.nic.in)). Journal of Indian Society of Periodontology encourages that the registration number be mentioned at the end of the abstract.

INCREASED EFFICIENCY IN USE OF LABORATORY ANIMALS {#sec1-5}
=================================================

Our ethical focus should be on the quality of research conducted and securing maximum welfare of animals. We can do this by reducing the number of animals used within each project, thereby making best use of each animal.

No science is above the need for validation. The ultimate responsibility for quality of the results lies with us. We alone know whether experiments were performed and interpreted appropriately or whether they represent data conveniently woven together to present the most appropriate results. We have to ensure that checks are in place regarding experimental design, data interpretation and presentation. Ultimately our work is our reputation.
